Stock update

It has been a while since I have posted here I know. I have been up in the air with many stocks and recently have been a little disappointed with Cell Therapeutics (CTIC). They have withdrawn the MMA for Opaxio and yes it seems they will be pursuing it more for ovarian cancer however I think it is very odd that they didn't try to figure which was the best thing Opaxio was good for before submitting a MMA. I also started having my doubts since Pixantrone was not granted priority review.

Hythiam (HYTM) is a company I am expecting to see a gain in the near future. They have a good treatment program and have their 3 year contract with Ford Motor Company (F). I believe there will be more contract announcements in the near future. I do not guarantee a profit on this or any stock personally.

Generex (GNBT) was awarded approval of use of Oral lyn for IND last month. They will be reporting earnings tonight at 6 PM.